| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Lianjun Shen | |
| Kenneth L Rock | |||
| P2860 | cites work | The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 |
| Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
| The ubiquitin system | Q27860803 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues | Q28115737 | ||
| An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides | Q28117783 | ||
| ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum | Q28205720 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
| Emerging roles for cysteine proteases in human biology | Q28306260 | ||
| ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells | Q28506676 | ||
| Phagosomes are competent organelles for antigen cross-presentation | Q28591811 | ||
| Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo | Q28595026 | ||
| In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens | Q29615098 | ||
| Ubiquitin: structures, functions, mechanisms | Q29616462 | ||
| IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors | Q29618425 | ||
| Molecular identification of a danger signal that alerts the immune system to dying cells | Q29619497 | ||
| Degradation of cell proteins and the generation of MHC class I-presented peptides | Q33652524 | ||
| Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen | Q33855119 | ||
| ER quality control: the cytoplasmic connection | Q41351861 | ||
| Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments | Q41379399 | ||
| A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules | Q41380874 | ||
| Dissociation of beta 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface | Q41683767 | ||
| Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules | Q41709457 | ||
| Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments | Q41724706 | ||
| Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading | Q41915734 | ||
| Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells | Q41942524 | ||
| Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis | Q42972789 | ||
| Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo | Q43582630 | ||
| Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors | Q43682665 | ||
| Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway | Q44539124 | ||
| Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation | Q44551901 | ||
| Antigen recognition. Class discrimination in the world of immunology | Q44582156 | ||
| Immunology: professional secrets | Q44595777 | ||
| Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 | ||
| Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages | Q45345587 | ||
| Cutting Edge: Conventional CD8α+ Dendritic Cells Are Preferentially Involved in CTL Priming After Footpad Infection with Herpes Simplex Virus-1 | Q45723907 | ||
| Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP. | Q45733549 | ||
| Introduction of soluble protein into the class I pathway of antigen processing and presentation | Q46305448 | ||
| Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses | Q47218007 | ||
| Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses | Q47218016 | ||
| Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles | Q47401757 | ||
| Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses | Q47421290 | ||
| Regulation of phagosome maturation by signals from toll-like receptors | Q47604798 | ||
| Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. | Q50167043 | ||
| In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. | Q50335816 | ||
| Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. | Q50335820 | ||
| Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. | Q51989826 | ||
| Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo | Q57227930 | ||
| Accessory to murder | Q58990660 | ||
| Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 | ||
| CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 | ||
| Cross-presentation in viral immunity and self-tolerance. | Q34119651 | ||
| A blast from the past: clearance of apoptotic cells regulates immune responses. | Q34162195 | ||
| Cross-presentation, dendritic cells, tolerance and immunity | Q34178099 | ||
| Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents | Q34189220 | ||
| Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells | Q34265522 | ||
| Antigen bias in T cell cross-priming | Q34323408 | ||
| Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. | Q34368354 | ||
| Antigen processing and presentation by the class I major histocompatibility complex | Q34389698 | ||
| A new foreign policy: MHC class I molecules monitor the outside world | Q34398620 | ||
| Phagocytosis and antigen presentation | Q34439309 | ||
| Mouse and human dendritic cell subtypes | Q34576401 | ||
| Roles of heat-shock proteins in innate and adaptive immunity | Q34576423 | ||
| Overview of vaccine adjuvants: present and future | Q34787693 | ||
| The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. | Q34801799 | ||
| Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus | Q34858946 | ||
| Viral interference with antigen presentation | Q34983830 | ||
| ER-mediated phagocytosis: a new membrane for new functions | Q35096184 | ||
| Activation of mammalian Toll-like receptors by endogenous agonists. | Q35195062 | ||
| Proteolysis, proteasomes and antigen presentation | Q35228583 | ||
| New tools for antigen delivery to the MHC class I pathway | Q35753113 | ||
| Endogenous ligands of Toll-like receptors | Q35792678 | ||
| Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens | Q35826361 | ||
| Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses | Q35851094 | ||
| Plasmacytoid dendritic cells in immunity | Q35953140 | ||
| Natural endogenous adjuvants. | Q35988793 | ||
| Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells | Q36066835 | ||
| Dendritic-cell-based therapeutic vaccination against cancer | Q36070700 | ||
| Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design | Q36072450 | ||
| Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells | Q36301001 | ||
| Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo | Q36350448 | ||
| Heat shock protein 70-associated peptides elicit specific cancer immunity | Q36362368 | ||
| Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis | Q36365348 | ||
| Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo | Q36367135 | ||
| Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake | Q36367262 | ||
| The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens | Q36371212 | ||
| Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo | Q36371253 | ||
| Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation | Q36376037 | ||
| Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens | Q36376041 | ||
| Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation | Q36376556 | ||
| Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity | Q36380745 | ||
| Different fates of phagocytosed particles after delivery into macrophage lysosomes. | Q36382371 | ||
| Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens | Q36400803 | ||
| Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
| Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction | Q36401408 | ||
| Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation | Q36475793 | ||
| Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens | Q36689895 | ||
| Trafficking of spontaneously endocytosed MHC proteins | Q36703975 | ||
| Cellular protein is the source of cross-priming antigen in vivo | Q36853548 | ||
| Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming | Q37089414 | ||
| Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection | Q37269276 | ||
| High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization | Q38339803 | ||
| Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells | Q38343128 | ||
| The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation | Q38557888 | ||
| Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells | Q40428518 | ||
| Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. | Q40481734 | ||
| CD8+ T cell cross-priming via transfer of proteasome substrates | Q40551130 | ||
| CpG-DNA aided cross-priming by cross-presenting B cells | Q40597304 | ||
| Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells | Q40614179 | ||
| Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages | Q40657222 | ||
| Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. | Q40677042 | ||
| Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages | Q40693930 | ||
| A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation | Q40746014 | ||
| Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo | Q40752712 | ||
| Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens | Q40761219 | ||
| Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization | Q40769880 | ||
| Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. | Q40773099 | ||
| Heat shock proteins transfer peptides during antigen processing and CTL priming | Q40798685 | ||
| Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules | Q40816546 | ||
| Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum | Q40822154 | ||
| Dendritic cells acquire antigens from live cells for cross-presentation to CTL. | Q40822225 | ||
| Mechanisms of phagocytosis | Q41053690 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation | Q41109895 | ||
| Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. | Q41262004 | ||
| P921 | main subject | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | Q14633881 |
| antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | Q14879085 | ||
| P304 | page(s) | 166-183 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Cross-presentation: underlying mechanisms and role in immune surveillance | |
| P478 | volume | 207 |
| Q27670921 | A Common Single Nucleotide Polymorphism in Endoplasmic Reticulum Aminopeptidase 2 Induces a Specificity Switch That Leads to Altered Antigen Processing |
| Q37964551 | A case of mistaken identity: HSPs are no DAMPs but DAMPERs. |
| Q36619698 | A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation. |
| Q36099514 | A computational docking study on the pH dependence of peptide binding to HLA-B27 sub-types differentially associated with ankylosing spondylitis |
| Q35941274 | A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses |
| Q37903403 | A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. |
| Q36256534 | A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells |
| Q24657992 | A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers |
| Q34412732 | A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. |
| Q35632808 | A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. |
| Q38476599 | A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity |
| Q36122915 | Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure. |
| Q34968934 | Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy |
| Q38129794 | Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments |
| Q55479842 | Active Role of the Necrotic Zone in Desensitization of Hypoxic Macrophages and Regulation of CSC-Fate: A hypothesis. |
| Q36716920 | Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen. |
| Q39576961 | Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity |
| Q37602176 | An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. |
| Q36229188 | An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells |
| Q37158563 | An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis |
| Q35137191 | An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells |
| Q33548677 | An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. |
| Q30376254 | Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. |
| Q37415528 | Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response |
| Q33752783 | Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation |
| Q44665378 | Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice |
| Q45316964 | Antigen processing-Cross presentation |
| Q33646495 | Antigen release kinetics in the phagosome are critical to cross-presentation efficiency |
| Q38087272 | Antigen-specific CD8(+) T cells and protective immunity to tuberculosis |
| Q38212549 | Applying biodegradable particles to enhance cancer vaccine efficacy |
| Q34055255 | Bacteria modulate the CD8+ T cell epitope repertoire of host cytosol-exposed proteins to manipulate the host immune response |
| Q41702560 | Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice |
| Q53579489 | Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation. |
| Q42045089 | Both CD4⁺ and CD8⁺ lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults |
| Q38161368 | C-type Lectin Receptors for Tumor Eradication: Future Directions |
| Q37358997 | CD8+ T cells in type 1 diabetes |
| Q44261970 | Carrying yourself: self antigen composition of the lymphatic fluid. |
| Q39320852 | Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines |
| Q36414246 | Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine |
| Q37901573 | Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells |
| Q34400527 | Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity |
| Q34218620 | Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms |
| Q46304257 | Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state |
| Q91855281 | Cross-presentation of Exogenous Antigens |
| Q38008346 | Cross-presentation: how to get there - or how to get the ER. |
| Q41909122 | Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+ CD4- dendritic cells. |
| Q36081115 | DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus |
| Q33730191 | DNA-encapsulated magnesium phosphate nanoparticles elicit both humoral and cellular immune responses in mice |
| Q28592721 | Defective cross-presentation of viral antigens in GILT-free mice |
| Q37945184 | Dendritic Cells in Innate and Adaptive Immune Responses against Influenza Virus |
| Q37309247 | Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors |
| Q34661797 | Dendritic cell-based vaccines: barriers and opportunities |
| Q34693251 | Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo |
| Q38829744 | Dendritic cells in inflammatory sinonasal diseases |
| Q36407174 | Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo |
| Q39768969 | Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB. |
| Q45927002 | Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells. |
| Q36026319 | Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines |
| Q39078869 | Encapsulation of poly(D,L-lactide) microparticles with polyelectrolyte multilayers for antigen delivery |
| Q28084299 | Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines |
| Q37381089 | Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination |
| Q47100509 | Evaluation of Aggregated Ag85B Antigen for Its Biophysical Properties, Immunogenicity, and Vaccination Potential in a Murine Model of Tuberculosis Infection |
| Q37534913 | Evasion and subversion of antigen presentation by Mycobacterium tuberculosis |
| Q28728395 | Evolutionary and functional relationships of B cells from fish and mammals: insights into their novel roles in phagocytosis and presentation of particulate antigen |
| Q34147894 | Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin |
| Q36959680 | Exploiting dendritic cells for active immunotherapy of cancer and chronic infections |
| Q39646814 | Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors |
| Q26747413 | Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity |
| Q33554629 | Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity |
| Q54616747 | Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrier. |
| Q35593603 | Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants |
| Q38445061 | From the draining lymph node to the liver: the induction and effector mechanisms of malaria-specific CD8+ T cells |
| Q35055154 | Full inactivation of human influenza virus by high hydrostatic pressure preserves virus structure and membrane fusion while conferring protection to mice against infection |
| Q26860153 | GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum |
| Q37077649 | Genetically engineered Tobacco mosaic virus as nanoparticle vaccines |
| Q41701124 | Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections |
| Q49530934 | Granulocytes: New Members of the Antigen-Presenting Cell Family. |
| Q40743173 | HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation |
| Q37980404 | Harnessing human plasmacytoid dendritic cells as professional APCs. |
| Q42086101 | Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. |
| Q35624884 | Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come |
| Q37341616 | How location governs toll-like receptor signaling |
| Q40043089 | Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells |
| Q57295207 | Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease |
| Q61812341 | Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy |
| Q30849501 | Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner. |
| Q30433374 | Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells |
| Q38124061 | Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults |
| Q34701587 | Immunotherapy of brain cancers: the past, the present, and future directions |
| Q35955224 | Increasing vaccine potency through exosome antigen targeting |
| Q36339378 | Inducible renitence limits Listeria monocytogenes escape from vacuoles in macrophages. |
| Q27309214 | Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity |
| Q37708023 | Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy |
| Q36898670 | Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients |
| Q37655007 | Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines |
| Q34705027 | Influenza vaccine responses in older adults |
| Q39039132 | Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells |
| Q26801963 | Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation |
| Q37438723 | Intracellular assembly and trafficking of MHC class I molecules |
| Q36858877 | Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. |
| Q33347601 | Isolation of bacteria-containing phagosomes by magnetic selection |
| Q34581001 | Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin |
| Q33614657 | Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity |
| Q36714774 | MHC class I antigens and immune surveillance in transformed cells. |
| Q37855532 | Macropinocytosis: an endocytic pathway for internalising large gulps |
| Q26781338 | Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications |
| Q41693151 | Modulation of Dendritic Cell Apoptosis and CD8+ Cytotoxicity by Histamine: Role of Protein Kinase C |
| Q36808693 | More than one reason to rethink the use of peptides in vaccine design |
| Q58034328 | Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion |
| Q35099713 | Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity |
| Q37002001 | NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. |
| Q42239683 | Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulation |
| Q38341522 | Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy |
| Q35182373 | Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response |
| Q36424493 | Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation |
| Q38208315 | Oncolytic virus-mediated reversal of impaired tumor antigen presentation |
| Q36616505 | Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease |
| Q38793294 | PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens |
| Q37694483 | PPE38 Protein of Mycobacterium tuberculosis Inhibits Macrophage MHC Class I Expression and Dampens CD8+ T Cell Responses |
| Q37369428 | Pathobiology of inflammation to cell death |
| Q37088488 | Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. |
| Q36602254 | Pathogen recognition and development of particulate vaccines: does size matter? |
| Q38008365 | Pathogenic CD8 T cells in multiple sclerosis and its experimental models |
| Q34023384 | Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1 |
| Q41819217 | Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. |
| Q35612698 | Poly(2-aminoethyl methacrylate) with well-defined chain length for DNA vaccine delivery to dendritic cells |
| Q40217887 | Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy |
| Q40473345 | Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity. |
| Q39601936 | Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. |
| Q33466076 | Priming of Salmonella enterica serovar typhi-specific CD8(+) T cells by suicide dendritic cell cross-presentation in humans |
| Q37724910 | Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. |
| Q34979864 | Proteases in MHC class I presentation and cross-presentation |
| Q33394150 | Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides |
| Q35635264 | Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells |
| Q39860495 | Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System |
| Q41458034 | Proteome-wide B and T cell epitope repertoires in outer membrane proteins of Mycobacterium avium subsp. paratuberculosis have vaccine and diagnostic relevance: a holistic approach |
| Q37500322 | RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells. |
| Q62015477 | RNAi screen for kinases and phosphatases that play a role in antigen presentation by dendritic cells |
| Q38101671 | Reactive oxygen species in the immune system |
| Q37097196 | Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells |
| Q37710630 | Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation |
| Q30392181 | Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis |
| Q34108177 | Regulation of CD8+ T cell responses to infection with parasitic protozoa |
| Q51410365 | Regulation of the Cell Biology of Antigen Cross-Presentation. |
| Q36539633 | Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis |
| Q30574747 | Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells |
| Q34077474 | Robust Stimulation of Humoral and Cellular Immune Responses following Vaccination with Antigen-Loaded β-Glucan Particles |
| Q33519555 | Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice |
| Q48161285 | SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma |
| Q38164258 | Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases |
| Q45867833 | Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation |
| Q30367426 | Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses |
| Q30482316 | Signaling and cross-talk by C5a and UDP in macrophages selectively use PLCbeta3 to regulate intracellular free calcium |
| Q36729670 | Signalling and phagocytosis in the orchestration of host defence |
| Q45873308 | Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells |
| Q64941421 | Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant. |
| Q37002795 | T-cell death and cancer immune tolerance |
| Q47941316 | TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites |
| Q34221791 | TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice |
| Q44997831 | TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses |
| Q34416204 | TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation |
| Q35204618 | TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells |
| Q37363754 | Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation |
| Q38577695 | The Role of Il-12 and Type I Interferon in Governing the Magnitude of CD8 T Cell Responses |
| Q37941760 | The TAP translocation machinery in adaptive immunity and viral escape mechanisms |
| Q41822549 | The Tricky Balancing Act of using Heat Shock Proteins for Cross-Presentation |
| Q33710401 | The Use of Xanthan Gum as Vaccine Adjuvant: An Evaluation of Immunostimulatory Potential in BALB/c Mice and Cytotoxicity In Vitro |
| Q40088629 | The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes. |
| Q37082455 | The cell biology of cross-presentation and the role of dendritic cell subsets |
| Q38869721 | The comings and goings of MHC class I molecules herald a new dawn in cross-presentation. |
| Q42672113 | The lymph as a pool of self-antigens |
| Q39409778 | The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen |
| Q38008364 | The role of heat shock proteins in antigen cross presentation |
| Q35928365 | The role of insulin-regulated aminopeptidase in MHC class I antigen presentation |
| Q37327058 | The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells |
| Q30440575 | The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines |
| Q36811131 | Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists |
| Q37240133 | Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine |
| Q91584288 | Thyroid cancer and the immune system: a model for effective immune surveillance |
| Q58910709 | Tipping the Proteome with Gene-Based Vaccines: Weighing in on the Role of Nanomaterials |
| Q40130950 | Transcription factor Batf3 is important for development of CD8+ T-cell response against a phagosomal bacterium regardless of the location of antigen |
| Q36396925 | Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection |
| Q35998125 | Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. |
| Q36652196 | Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones |
| Q37348861 | Vaccination with tumor cells pulsed with foreign peptide induces immunity to the tumor itself |
| Q38081910 | Vaccine strategies for glioblastoma: progress and future directions |
| Q38243975 | Vaccine therapies for patients with glioblastoma |
| Q34170074 | Vaccines and immunotherapeutics for the treatment of malignant disease |
| Q33344607 | Vitiligo puzzle: the pieces fall in place |
Search more.